Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend
Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend

May 30, 2013

Vinge has advised Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend, one of Norway’s largest veterinary clinics. A joint project is planned for the construction of a new veterinary hospital in Bergen. Djursjukhusgruppen is the Nordic region’s leading group of companies providing advanced veterinary care for dogs, cats and other pets.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Alexandra Kempe, Magnus Wieslander and Gustav Jönsson.

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026